For the year ending 2025-12-31, FLGT made $322,671K in revenue. -$60,513K in net income. Net profit margin of -18.75%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 322,671 | 283,470 | ||
| Cost of revenue | 191,796 | 176,255 | ||
| Gross profit | 130,875 | 107,215 | ||
| Research and development | 53,905 | 48,816 | ||
| Selling and marketing | 43,371 | 36,246 | ||
| General and administrative | 116,664 | 88,106 | ||
| Amortization of intangible assets | 8,031 | 7,965 | ||
| Total operating expenses | 221,971 | 181,133 | ||
| Operating loss | -91,096 | -73,918 | ||
| Impairment of available-for-sale debt securities | - | 10,073 | ||
| Interest income | 30,919 | 31,304 | ||
| Interest expense | 75 | -170 | ||
| Impairment loss | 9,926 | - | ||
| Other income, net | 153 | 561 | ||
| Total other income, net | 21,071 | 21,962 | ||
| Loss before income taxes | -70,025 | -51,956 | ||
| (benefit from) provision for income taxes | -8,394 | -8,136 | ||
| Net loss from consolidated operations | -61,631 | -43,820 | ||
| Net loss attributable to noncontrolling interests | -1,118 | -1,112 | ||
| Net loss attributable to fulgent | -60,513 | -42,708 | ||
| Basic Average Shares | 30,777,000 | 30,235,000 | ||
| Diluted Average Shares | 30,777,000 | 30,235,000 | ||
Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc. (FLGT)